NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)
This study is currently recruiting participants.
Verified July 2012 by Noxxon Pharma AG
Sponsor:
Noxxon Pharma AG
Information provided by (Responsible Party):
Noxxon Pharma AG
ClinicalTrials.gov Identifier:
NCT01486797
First received: December 1, 2011
Last updated: February 22, 2013
Last verified: July 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2015 |
| Estimated Primary Completion Date: | June 2014 (Final data collection date for primary outcome measure) |